149 related articles for article (PubMed ID: 14505914)
1. Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells.
Blaney JE; Manipon GG; Firestone CY; Johnson DH; Hanson CT; Murphy BR; Whitehead SS
Vaccine; 2003 Oct; 21(27-30):4317-27. PubMed ID: 14505914
[TBL] [Abstract][Full Text] [Related]
2. Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells.
Blaney JE; Johnson DH; Manipon GG; Firestone CY; Hanson CT; Murphy BR; Whitehead SS
Virology; 2002 Aug; 300(1):125-39. PubMed ID: 12202213
[TBL] [Abstract][Full Text] [Related]
3. Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.
Blaney JE; Johnson DH; Firestone CY; Hanson CT; Murphy BR; Whitehead SS
J Virol; 2001 Oct; 75(20):9731-40. PubMed ID: 11559806
[TBL] [Abstract][Full Text] [Related]
4. Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys.
Whitehead SS; Hanley KA; Blaney JE; Gilmore LE; Elkins WR; Murphy BR
Vaccine; 2003 Oct; 21(27-30):4307-16. PubMed ID: 14505913
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of molecular strategies to develop a live dengue vaccine.
Lai CJ; Bray M; Men R; Cahour A; Chen W; Kawano H; Tadano M; Hiramatsu K; Tokimatsu I; Pletnev A; Arakai S; Shameem G; Rinaudo M
Clin Diagn Virol; 1998 Jul; 10(2-3):173-9. PubMed ID: 9741643
[TBL] [Abstract][Full Text] [Related]
6. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
7. Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.
Hanley KA; Manlucu LR; Manipon GG; Hanson CT; Whitehead SS; Murphy BR; Blaney JE
Vaccine; 2004 Sep; 22(25-26):3440-8. PubMed ID: 15308370
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys.
Blaney JE; Speicher J; Hanson CT; Sathe NS; Whitehead SS; Murphy BR; Pletnev AG
Vaccine; 2008 Aug; 26(33):4150-9. PubMed ID: 18586359
[TBL] [Abstract][Full Text] [Related]
9. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.
Pletnev AG; Claire MS; Elkins R; Speicher J; Murphy BR; Chanock RM
Virology; 2003 Sep; 314(1):190-5. PubMed ID: 14517072
[TBL] [Abstract][Full Text] [Related]
10. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.
Pletnev AG; Swayne DE; Speicher J; Rumyantsev AA; Murphy BR
Vaccine; 2006 Sep; 24(40-41):6392-404. PubMed ID: 16831498
[TBL] [Abstract][Full Text] [Related]
11. Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in mice.
Lee HC; Yen YT; Chen WY; Wu-Hsieh BA; Wu SC
PLoS One; 2011; 6(10):e25800. PubMed ID: 22053180
[TBL] [Abstract][Full Text] [Related]
12. Paired charge-to-alanine mutagenesis of dengue virus type 4 NS5 generates mutants with temperature-sensitive, host range, and mouse attenuation phenotypes.
Hanley KA; Lee JJ; Blaney JE; Murphy BR; Whitehead SS
J Virol; 2002 Jan; 76(2):525-31. PubMed ID: 11752143
[TBL] [Abstract][Full Text] [Related]
13. Temperature sensitive mutations in the genes encoding the NS1, NS2A, NS3, and NS5 nonstructural proteins of dengue virus type 4 restrict replication in the brains of mice.
Blaney JE; Manipon GG; Murphy BR; Whitehead SS
Arch Virol; 2003 May; 148(5):999-1006. PubMed ID: 12721805
[TBL] [Abstract][Full Text] [Related]
14. Chimeric dengue 2 PDK-53/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus.
Huang CY; Silengo SJ; Whiteman MC; Kinney RM
J Virol; 2005 Jun; 79(12):7300-10. PubMed ID: 15919884
[TBL] [Abstract][Full Text] [Related]
15. Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.
Huang CY; Butrapet S; Tsuchiya KR; Bhamarapravati N; Gubler DJ; Kinney RM
J Virol; 2003 Nov; 77(21):11436-47. PubMed ID: 14557629
[TBL] [Abstract][Full Text] [Related]
16. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.
Blaney JE; Sathe NS; Hanson CT; Firestone CY; Murphy BR; Whitehead SS
Virol J; 2007 Feb; 4():23. PubMed ID: 17328799
[TBL] [Abstract][Full Text] [Related]
17. Induction of bivalent immune responses by expression of dengue virus type 1 and type 2 antigens from a single complex adenoviral vector.
Raja NU; Holman DH; Wang D; Raviprakash K; Juompan LY; Deitz SB; Luo M; Zhang J; Porter KR; Dong JY
Am J Trop Med Hyg; 2007 Apr; 76(4):743-51. PubMed ID: 17426182
[TBL] [Abstract][Full Text] [Related]
18. A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4.
Hanley KA; Manlucu LR; Gilmore LE; Blaney JE; Hanson CT; Murphy BR; Whitehead SS
Virology; 2003 Jul; 312(1):222-32. PubMed ID: 12890635
[TBL] [Abstract][Full Text] [Related]
19. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
[TBL] [Abstract][Full Text] [Related]
20. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.
Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG
Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
